189 related articles for article (PubMed ID: 37735421)
1. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
[TBL] [Abstract][Full Text] [Related]
2. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
3. TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.
Flodrops M; Dujardin G; Busson A; Trouvé P; Ka C; Simon B; Arzur D; Le Jossic-Corcos C; Corcos L
Mol Biol Rep; 2020 Apr; 47(4):3031-3040. PubMed ID: 32200451
[TBL] [Abstract][Full Text] [Related]
4. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
Wan L; Yu W; Shen E; Sun W; Liu Y; Kong J; Wu Y; Han F; Zhang L; Yu T; Zhou Y; Xie S; Xu E; Zhang H; Lai M
Gut; 2019 Jan; 68(1):118-129. PubMed ID: 29114070
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer.
Pan YJ; Huo FC; Kang MJ; Liu BW; Wu MD; Pei DS
Clin Transl Med; 2022 Nov; 12(11):e1113. PubMed ID: 36394206
[TBL] [Abstract][Full Text] [Related]
7. Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer.
Huang KK; Huang J; Wu JKL; Lee M; Tay ST; Kumar V; Ramnarayanan K; Padmanabhan N; Xu C; Tan ALK; Chan C; Kappei D; Göke J; Tan P
Genome Biol; 2021 Jan; 22(1):44. PubMed ID: 33482911
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.
Lian H; Wang A; Shen Y; Wang Q; Zhou Z; Zhang R; Li K; Liu C; Jia H
BMC Gastroenterol; 2020 Jun; 20(1):171. PubMed ID: 32503434
[TBL] [Abstract][Full Text] [Related]
9. The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.
Lin JC; Lee YC; Liang YC; Fann YC; Johnson KR; Lin YJ
Sci Rep; 2017 Mar; 7():44204. PubMed ID: 28276498
[TBL] [Abstract][Full Text] [Related]
10. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
[TBL] [Abstract][Full Text] [Related]
11. Revised Exon Structure of l-DOPA Decarboxylase (
Artemaki PI; Papatsirou M; Boti MA; Adamopoulos PG; Christodoulou S; Vassilacopoulou D; Scorilas A; Kontos CK
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202911
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
[TBL] [Abstract][Full Text] [Related]
13. Integration of single-cell transcriptomics and epigenetic analysis reveals enhancer-controlled TIMP1 as a regulator of ferroptosis in colorectal cancer.
Li M; Ni QY; Yu SY
Genes Genomics; 2024 Jan; 46(1):121-133. PubMed ID: 38032469
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.
Snezhkina AV; Krasnov GS; Zaretsky AR; Zhavoronkov A; Nyushko KM; Moskalev AA; Karpova IY; Afremova AI; Lipatova AV; Kochetkov DV; Fedorova MS; Volchenko NN; Sadritdinova AF; Melnikova NV; Sidorov DV; Popov AY; Kalinin DV; Kaprin AD; Alekseev BY; Dmitriev AA; Kudryavtseva AV
BMC Genomics; 2016 Dec; 17(Suppl 14):1011. PubMed ID: 28105922
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer.
Wang C; Weng M; Xia S; Zhang M; Chen C; Tang J; Huang D; Yu H; Sun W; Zhang H; Lai M
Cancer Sci; 2021 Jan; 112(1):178-193. PubMed ID: 33058325
[TBL] [Abstract][Full Text] [Related]
16. CLASRP oncogene as a novel target for colorectal cancer.
Gu Q; Wu J; Xu H; Cao H; Zhang J; Jing C; Wang Z; Du M; Ma R; Feng J
Funct Integr Genomics; 2023 Sep; 23(3):290. PubMed ID: 37658940
[TBL] [Abstract][Full Text] [Related]
17. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
[TBL] [Abstract][Full Text] [Related]
18. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
19. Dynamic nanopore long-read sequencing analysis of HIV-1 splicing events during the early steps of infection.
Nguyen Quang N; Goudey S; Ségéral E; Mohammad A; Lemoine S; Blugeon C; Versapuech M; Paillart JC; Berlioz-Torrent C; Emiliani S; Gallois-Montbrun S
Retrovirology; 2020 Aug; 17(1):25. PubMed ID: 32807178
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing.
Wu Y; Wang X; Wu F; Huang R; Xue F; Liang G; Tao M; Cai P; Huang Y
PLoS One; 2012; 7(8):e41001. PubMed ID: 22905095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
